Turnover: 700000 EUR (2019)
Country: France
We are an innovative clinical-stage gene therapy company dedicated to the discovery, development and commercialization of innovative therapies for patients with severe neurodegenerative diseases of the retina.
Studies mentioning this company
The gene therapy market - France
Other companies mentioned:
- Sanofi Aventis
- Cellectis
- Généthon
- Gensight Biologics